diabetes glp-1 agonist Receptor Agonists: A Game-Changer for Type 2 How GLP-1 Receptor Agonists Evolved
Description
high blood pressure
This raises the question of whether some patients might require longer treatment to sustain weight loss
Finan B, Ma T, Ottaway N, Muller TD, Habegger KM, Heppner KM, et al
In December of 2017, the U.S Food and Drug Administration (FDA) approved Novo Nordisks semaglutide (brand name Ozempic) for the treatment of type-2 diabetes
New England Journal of Medicine, 388(3), 251263
Therefore, surgical intervention should be deferred until the patient has achieved weight stability and optimized nutritional status
